AVROBIO

AVROBIO

Biotechnology Research 100 Technology Sq 18 employees
Employees
18
Contacts
3
Emails
3
Phones
3

AVROBIO Overview

Headquarters
100 Technology Sq
Phone Number
Available in AeroLeads
Website
avrobio.com
Industry
Biotechnology Research
Employees
18
Funding
60.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About AVROBIO

Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. We are headquartered in Cambridge, Mass. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn.

AVROBIO Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
3
75.0% coverage

AVROBIO Org Chart

Sample employees and titles
Name Title Contact
Ingrid Damacela Manufacturing and Technology Operations Leader (Ms&t) - Cell and Gene Therapy - Cdmo Management - Cmc - Process Improvement - Gmp Mfg
View
Joseph Davis Information Technology Leader
Email Phone
Mathews Adera, Md Vice President Clinical Development, Avrobio Inc
Email Phone
Bruce Booth Partner at Atlas Venture
Email Phone

Employees by Management Level

Individual contributor 8 profiles
Executive 2 profiles
Manager 2 profiles
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 0
Executive 1 1 1

AVROBIO Tech Stack

Data / AI 1 profile
Product / design 1 profile

Compare Similar Companies to AVROBIO